Skip to main content
SpringerLink
Log in

Cancer Prevention II

  • Conference proceedings
  • © 2009

Overview

Editors:
  1. Hans-Jörg Senn

    1. Zentrum fücr Tumordiagnostik und Prävention, St. Gallen, Schweiz

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Ursula Kapp

    1. Zentrum fücr Tumordiagnostik und Prävention, St. Gallen, Schweiz

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Florian Otto

    1. Zentrum fücr Tumordiagnostik und Prävention, St. Gallen, Schweiz

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 181)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (22 papers)

  1. Front Matter

    Pages i-xx
    Download chapter PDF

  2. Cancer Prevention and Health Politics

    1. Do We Make Optimal Use of the Potential of Cancer Prevention?

      • Peter Greenwald, Barbara K. Dunn
      Pages 3-17

    2. Predictors of Successful Cancer Prevention Programs

      • Franz Porzsolt, Anita Kirner, Robert M. Kaplan
      Pages 19-31

    3. Cancer Prevenpinon in the Developing World: Mission Impossible?

      • Franco Cavalli
      Pages 33-39

    4. Is Cancer Prevention Ever Going to Be Profitable?

      • Thomas D. Szucs, Konstantin J. Dedes
      Pages 41-47

  3. Cancer Prevention: The Scientific-Epidemiological Base

    1. Energy Metabolism, Cancer Risk, and Cancer Prevention

      • Michael Pollak
      Pages 51-54

    2. Promises and Limitations of Biomarkers

      • David F. Ransohoff
      Pages 55-59

  4. Cancer Prevention, Tobacco and Nutrition

    1. The EPIC Study: An Update

      • Paolo Vineis, Elio Riboli
      Pages 63-70

    2. Anti-angiogenic properties of Chemopreventive Drugs: Fenretinide as a Prototype.

      • Ilaria Sogno, Roberta Venè, Cristina Sapienza, Nicoletta Ferrari, Francesca Tosetti, Adriana Albini
      Pages 71-76

    3. Retinoids and Breast Cancer Prevention

      • Bernardo Bonanni, Matteo Lazzeroni
      Pages 77-81

  5. Cancer Prevention, Genetics and Vaccines

    1. Cancer Prevention by Vaccination Against Hepatitis B

      • Mei-Hwei Chang
      Pages 85-94

  6. Cancer Prevention and Target Organs I: Breast Cancer

    1. Energy Restriction for Breast Cancer Prevention

      • Anthony Howell, Mary Chapman, Michelle Harvie
      Pages 97-111

    2. The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer

      • D. Lawrence Wickerham, Joseph P. Costantino, Victor G. Vogel, Walter M. Cronin, Reena S. Cecchini, Leslie G. Ford et al.
      Pages 113-119

    3. Prevention of ER-Negative Breast Cancer

      • Yuxin Li, Powel H. Brown
      Pages 121-134

    4. EHxoorgmeonnoeuss, aMnadmEmndooggraepnhoiucs Density and Breast Cancer Risk: Can Mammographic Density Be Considered an Intermediate Marker of Risk?

      • Susen Becker, Rudolf Kaaks
      Pages 135-157

  7. Cancer Prevention and Target Organs II: Cancer of the Digestive Tract

    1. Chemoprevention of Oesophageal Cancer and the AspECT Trial

      • Debasish Das, Andrew P. Chilton, Janusz A. Jankowski
      Pages 161-169

  8. Cancer Prevention and Target Organs III: Prostate Cancer

    1. Review of Diagnostic Markers for Prostate Cancer 16

      • Fritz H. Schröder
      Pages 173-182

    2. Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer Prevention

      • Barbara K. Dunn, Anne Ryan, Leslie G. Ford
      Pages 183-193

    3. Prostate Cancer Prevention by Short-Term Anti-androgens: The Rationale Behind Design of Pilot Studies

      • Tim Oliver, Attila Lorincz, Jack Cuzick
      Pages 195-205

  9. Cancer Prevention and Target Organs III: Prostate Cancer

    1. Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids

      • Ilaria Sogno, Nicola Vannini, Girieca Lorusso, Rosaria Cammarota, Douglas M. Noonan, Luca Generoso et al.
      Pages 209-212
Back to top

Keywords

About this book

More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on “Primary Therapy of Early Breast Cancer” as well as “Supportive Care in Cancer” for more than 20 years, the idea of promoting interdisciplinary, clinically oriented meetings on cancer prevention is a more recent and not yet generally accepted and w- comed concept in modern oncology. Since today’s medical expenses are soaring and me- cal research budgets are stagnating or even being cut, neither politicians nor industry is willing to risk an additional unpredictable channel of expenses, such as that demanded by clinical cancer prevention efforts! In Switzerland—and we fear in many other parts of the globe—some 97%–98% or even a greater percentage of health budgets is spent for curative and palliative/rehabilitative m- icine. Since a meager 2%–3% of national health budgets is for preventive medicine, even less than that proportion is specifically allocated for cancer prevention. When the money for “curing and caring” for the diseased populace runs short, there is likely not much left for partly controversial disease prevention in the (still) healthy part of the population.

Editors and Affiliations

  • Zentrum fücr Tumordiagnostik und Prävention, St. Gallen, Schweiz

    Hans-Jörg Senn, Ursula Kapp, Florian Otto

Bibliographic Information

  • Book Title: Cancer Prevention II

  • Editors: Hans-Jörg Senn, Ursula Kapp, Florian Otto

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-540-69297-3

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2009

  • Hardcover ISBN: 978-3-540-69296-6Published: 10 December 2008

  • Softcover ISBN: 978-3-642-08881-0Published: 22 November 2010

  • eBook ISBN: 978-3-540-69297-3Published: 28 November 2008

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: XX, 252

  • Number of Illustrations: 14 b/w illustrations, 14 illustrations in colour

  • Topics: Oncology, Cancer Research

Publish with us

Policies and ethics

Back to top

Search

Navigation